The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes β-catenin/TCF-mediated transcription

Carcinogenesis

Volumn 31, Issue 3, 2010, Pages 394-401

  Navarro, Diego ^a   Agra, Noelia ^a,b   Pestaña, Ángel ^a   Alonso, Javier ^a,b   González Sancho, José M ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; HYBRID PROTEIN; LYMPHOID ENHANCER FACTOR 1; PROTEIN VP16; RNA BINDING PROTEIN EWS; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR FLI 1; WNT PROTEIN; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; CTNNB1 PROTEIN, HUMAN; DKK1 PROTEIN, HUMAN; EWS FLI FUSION PROTEIN; EWS-FLI FUSION PROTEIN; LEF1 PROTEIN, HUMAN; ONCOPROTEIN; SIGNAL PEPTIDE; TCF4 PROTEIN, HUMAN; TCF7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7; TUMOR PROTEIN;

ARTICLE; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EWING SARCOMA; GENE ACTIVATION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; NEUROECTODERM TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; REPORTER GENE; TRANSACTIVATION; TUMOR GROWTH; BIOSYNTHESIS; DRUG ANTAGONISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; METABOLISM; MULTIGENE FAMILY; PATHOLOGY; PHYSIOLOGY; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; TUMOR CELL LINE;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOID ENHANCER-BINDING FACTOR 1; MULTIGENE FAMILY; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS, GENETIC; PROTEIN INTERACTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA, EWING'S; T CELL TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSGENES; WNT PROTEINS;

EID: 77950901872     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp317     Document Type: Article

References (46)

1. Rodriguez-Galindo, C. et al. (2003) Treatment of Ewing sarcoma family of tumours: current status and outlook for the future. Med. Pediatr. Oncol., 40, 276-287.
2. Kovar, H. (1998) Ewing's sarcoma and peripheral primitive neuroectodermal tumours after their genetic union. Curr. Opin. Oncol., 10, 334-342.
3. Arvand, A. et al. (2001) Biology of EWS/ETS fusions in Ewing's family tumours. Oncogene, 20, 5747-5754.
4. Delattre, O. et al. (1992) Gene fusion with an ETS DNA-binding domain caused by chromosomal translocation in human tumours. Nature, 359, 162-165.
5. Janknecht, R. (2005) EWS-ETS oncoproteins: the linchpins of Ewing tumours. Gene, 363, 1-14.
6. Gordon, M.D. et al. (2006) Wnt signalling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem., 281, 22429-22433.
7. Kawano, Y. et al. (2003) Secreted antagonists of the Wnt signaling pathway. J. Cell Sci., 116, 2627-2634.
8. Niehrs, C. (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene, 25, 7469-7481.
9. Bafico, A. et al. (2001) Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat. Cell Biol., 3, 683-686.
10. Mao, B. et al. (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature, 411, 321-325.
11. Mao, B. et al. (2002) Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature, 417, 664-667.
12. Semenov, M.V. et al. (2001) Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr. Biol., 11, R592-R595.
13. Pendás-Franco, N. et al. (2008) Vitamin D and Wnt/β-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res., 28, 2613-2624.
14. Gregory, C.A. et al. (2005) Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow. J. Biol. Chem., 280, 2309-2323.
15. Morvan, F. et al. (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J. Bone Miner. Res., 21, 934-945.
16. Tian, E. et al. (2003) The role of the Wnt-signalling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N. Engl. J. Med., 349, 2483-2494.
17. Mazziotti, G. et al. (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol. Metab., 17, 144-149.
18. Ohnaka, K. et al. (2004) Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoidinduced osteoporosis. Biochem. Biophys. Res. Commun., 318, 259-264.
19. Christodoulides, C. et al. (2006) The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J. Cell Sci., 119, 2613-2620.
20. Pinto, D. et al. (2003) Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev., 17, 1709-1713.
21. Kuhnert, F. et al. (2004) Essential requirement for Wnt signalling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc. Natl Acad. Sci. USA, 101, 266-271.
22. Endo, Y. et al. (2008) Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumour cells via a Frizzled3and c-Jun N-terminal kinasedependent mechanism. Mol. Cell. Biol., 28, 2368-2379.
23. Niida, A. et al. (2004) DKK1, a negative regulator of Wnt signalling, is a target of the β-catenin/TCF pathway. Oncogene, 23, 8520-8526.
24. González-Sancho, J.M. et al. (2005) The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer. Oncogene, 24, 1098-1103.
25. Chamorro, M.N. et al. (2005) FGF-20 and DKK1 are transcriptional targets of β-catenin and FGF-20 is implicated in cancer and development. EMBO J., 24, 73-84.
26. Aguilera, O. et al. (2007) The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis, 28, 1877-1884.
27. Aguilera, O. et al. (2006) Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene, 25, 4116-4121.
28. Carrillo, J. et al. (2007) Cholecystokinin down-regulation by RNA interference impairs Ewing tumour growth. Clin. Cancer Res., 13, 2429-2440.
29. García-Aragoncillo, E. et al. (2008) DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. Oncogene, 27, 6034-6043.
30. Korinek, V. et al. (1997) Constitutive transcriptional activation by a betacatenin-Tcf complex in APC-/colon carcinoma. Science, 275, 1784-1787.
31. Hsieh, J.J. et al. (2005) Truncated mammalian Notch1 activates CBF1/RBPJk-represed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol. Cell. Biol., 16, 952-959.
32. Mendiola, M. et al. (2006) The orphan nuclear receptor DAX1 is upregulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumours. Int. J. Cancer, 118, 1381-1389.
33. Palmer, H.G. et al. (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signalling. J. Cell Biol., 154, 369-387.
34. Prieur, A. et al. (2004) EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein. Mol. Cell. Biol., 24, 7275-7283.
35. Kinsey, M. et al. (2006) NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI1 in Ewing sarcoma. Mol. Cancer Res., 4, 851-859.
36. Clevers, H. (2006) Wnt/β-catenin signalling in development and disease. Cell, 127, 469-480.
37. Subramanian, A. et al. (2005) Gene set enrichment analysis: a knowledgebased approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550.
38. Xie, X. et al. (2005) Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature, 434, 338-345.
39. Pascual, G. et al. (2006) Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol. Metab., 17, 321-327.
40. 2 vitamin D. Curr. Opin. Nephrol. Hypertens., 16, 297-304.
41. Üren, A. et al. (2004) Wnt/Frizzled signalling in Ewing sarcoma. Pediatr. Blood Cancer, 43, 243-249.
42. Miyagawa, Y. et al. (2009) EWS/ETS regulates the expression of the Dickkopf family in Ewing family tumor cells. PLoS One, 4, e4637.
43. Matushansky, I. et al. (2007) Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J. Clin. Invest., 117, 3248-3257.
44. Lee, A.Y. et al. (2004) Dickkopf-1 antagonizes Wnt signalling independent of beta-catenin in human mesothelioma. Biochem. Biophys. Res. Commun., 323, 1246-1250.
45. Mikheev, A.M. et al. (2004) A functional genomics approach for the identification of putative tumour suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation. Carcinogenesis, 25, 47-59.
46. Peng, S. et al. (2006) Dickkopf-1 induced apoptosis in human placental choriocarcinoma is independent of canonical Wnt signaling. Biochem. Biophys. Res. Commun., 350, 641-647.